高度可扩展的预输稳定RSV F疫苗具有增强的免疫性和强大的保护
Qingrui Huang1, Qingyun Lang2,3, Yao Li2
1Changping Laboratory, Beijing, China. huangqr@cpl.ac.cn.
Nature communications
|August 21, 2025
概括
一种新的普罗林扫描策略稳定了呼吸道同胞病毒 (RSV) 前输F蛋白,促进了疫苗的开发. 这种方法产生了稳定的抗原 (preF7P),具有改善的免疫性和对RSV菌株的广泛保护.
科学领域:
- 疫苗学
- 结构生物学
- 蛋白质工程
背景情况:
- 稳定呼吸道同胞病毒 (RSV) F蛋白质在其输血前形状对于疫苗的有效性至关重要,但也带来了重大挑战.
- 稳定F蛋白的常规方法通常效率低下,表达水平低.
研究的目的:
- 开发一种新且有效的稳定RSV前输F抗原的策略.
- 创建一个稳定的预注射F (preF) 抗原变体,具有增强的免疫性和保护能力.
主要方法:
- 采用了素扫描策略,将七种素替代物引入RSV F蛋白中以实现稳定.
- 结构和生化验证证了preF7P变体保持预注射形状的能力.
- 在小鼠和棉鼠模型中评估了免疫性和保护效果,并对非人类灵长类动物进行了评估.
主要成果:
- 在 preF7P 变种中,在预注射形状上表现出结构和生化稳定性.
- 与现有的DS-cav2抗原相比,PreF7P具有更高的免疫性,中和抗体标位增加了1. 8倍.
- 在临床前模型中,preF7P抗原提供了对RSV A和B菌株的保护,并在临床研究中引起了强大的,持续的免疫反应.
结论:
- 素扫描策略提供了一种有效和精简的方法来稳定RSV F蛋白等I类融合蛋白.
- 预F7P抗原是开发下一代RSV疫苗的有希望的候选者.
- 这种方法有可能加速用于I类融合蛋白的其他病毒病原体的疫苗开发.
相关概念视频
Vaccinations
Overview
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...


